Analysis of the spread of drug resistance mutations in the HIV-1 pol gene among the HIV-infected in the Irkutsk Region

Plotnikova Yu.K., Ponomareva O.A., Revizor A.O., Kruglova E.A.

Irkutsk Regional Center for the Prevention and Control of AIDS and Infectious Diseases
Objective. To estimate the situation associated with the spread of HIV subtypes, recombinant forms, and resistant variants in the Irkutsk Region.
Material and methods. The paper gives the data of analyzing the nucleoside sequences of the HIV-1 pol gene encoding the enzymes: protease, reverse transcriptase, and integrase. The investigation used plasma from 65 HIV-infected patients residing in the Irkursk Region. Commercial test systems were employed to isolate RNA and reverse transcription-polymerase chain reaction and cyclic sequencing were carried out. Nucleotide sequences were detected by capillary electrophoresis in an automated molecular analyzer.
Results. Phylogenetic analysis showed that 62 (95.38%) sequences were clustered with the HIV-1 genetic subtype A1 IDU-A variant, 2 samples were grouped with the recombinant form CRF02-AG, and one sample was with subtype B. Antiretroviral drug-resistant virus strains were detected in 63% of the patients. There was a broad spectrum of drug-resistant strains: those resistant to protease inhibitors in 10.77% of cases, nucleoside reverse transcriptase inhibitors in 58.46%, non-nucleoside reverse transcriptase inhibitors in 35.38%, and integrase inhibitors in 3.08%. The proportion of mono- and multidrug-resistant (to two or more drug) strains was 34.15 and 65.85%, respectively.
Conclusion. In the Irkutsk Region, there is a predominance of HIV-1 subtype A1; the detection of other subtypes suggests that the population’s migration may increase. The spectrum of drug-resistant strains corresponds to the highly active antiretroviral therapy regimens that are most commonly used in our region.


  1. Hemelaar J. Implications of HIV diversity for the HIV-1 pandemic. Journal of Infections 2013; 66: 391–400.
  2. HIV Sequence Compendium 2015. COMPENDIUM/2015compendium.html. Accessed September 15, 2015.
  3. Bobkova M. Current status of HIV-1 diversity and drug resistance monitoring in the former USSR. AIDS Rev. 2013; 15: 204–212.
  4. Dement’yeva N.Ye., Sizova N.V., Lisitsyna Z.N., Belyakov N.A. [Molecular and epidemiologic characteristic of HIV infection in Saint-Petersburg]. Meditsinskii akademicheskii zhurnal 2012; 12(2): 97–104. (In Russ.).
  5. Lapovok I.A., Laga V.Yu., Vasil’ev A.V., Salamov G.G., Kazennova Ye.V., Matkovsky I.A., Mokhniy G.A., Melnik T.A., Bobkova M.P. [Molecular genetic analysis of pol gene region coding for HIV-1 integrase in patients from Russia and Ukraine]. VICh-infektsiya i immunosupressii 2012; 4(2): 73–81. (In Russ.).
  6. Bernard E.J., Azad Y., Vandamme A.M., Weait M., Geretti A.M. HIV forensics: pitfalls and acceptable standards in the use of phylogenetic analysis as evidence in criminal investigations of HIV transmission. HIV Medicine 2007; 8: 382–387.
  7. Metzker M.L., Mindell D.P., Liu X.M., Ptak R.G., Gibbs R.A., Hillis D.M. Molecular evidence of HIV-1 transmission in a criminal case. PNAS 2002; 99(22): 14292–14297.
  8. Belyakov N.A., Rosental V.V., Dement’eva N.Ye., Vinogradova T.N., Sizova N.V. [Mathematical modelling and general trends of circulation of HIV subtypes and recombinant forms]. VICh-infektsiya i immunosupressii 2012; 4(2): 7–18. (In Russ.).
  9. Lebedev A.V., Kazennova E.V., Laga V.Yu., Lapovok I.A., Glushchenko N.V., Bobkova M.R., Plotnikova Yu.K., Ponomareva O.A., Neshumaev D.A. [Characterization of genetic variants of HIV-1, isolated on the territory of the Irkutsk region in 2012]. XXII Rossiyskiy natsionalniy kongress «Chelovek i lekarstvo». Tezisyi dokladov. Mosсow, 2015; 227. (In Russ.).
  10. Tamura K., Nei M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Molecular Biology and Evolution 1993; 10: 512–526.
  11. Tamura K., Stecher G., Peterson D., Filipski A., Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Molecular Biology and Evolution 2013; 30: 2725–2729.
  12. Kazennova E., Lapovok I., Vasilyev A., Laga V., Grezina L., Valova L., Bobkova M. [Problems of subtyping of HIV-1 on the base of pol gene and ways of their permission]. VICh-infektsiya i Immunosupressii 2010; 2(3): 42–48. (In Russ.).
  13. Struck D., Lawyer G., Ternes A., Schmit J., Perez Bercoff D. COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification. Nucleic Acids Research 2014; 42(18): 144–155.
  14. Agwu A.L., Bethel J., Hightow-Weidman L.B., Sleasman J.W., Wilson C.M., Rudy B., Kapogiannis B.G. Substantial multiclass transmitted drug resistance and drug-relevant polymorphisms among treatment-I behaviorally HIV-Infected youth. AIDS Patient Care and STDs 2012; 26(4): 193–196.
  15. Murillo W., Morales S., Paz-Bailey G., Castillo J., Pascale J.M., Albert J., Lorenzana de Rivera I. Transmitted drug resistance among newly diagnosed HIV-1 infected individuals in three Central American countries. 6th IAS Conference on HIV Pathogenesis. Treatment and Prevention. July 17–20, 2011, Roma.
  16. Taylor S., Allen S., Fidler S., White D., Gibbson S. Stop Study: After discontinuation of efavirenz, plasma concentrations may persist for 2 weeks or longer. 11th Conference on retroviruses and opportunistic infections. February 8, 2004, San Francisco.

About the Autors

For correspondence:
Revizor Alexander Olegovich, Biologist, Department of Molecular Biological Studies, Irkutsk Regional Center for the Prevention and Control of AIDS and Infectious Diseases
Address: 11 Spartakovskaya St., Irkutsk 664035
Telephone: +7(3952) 77-79-58

Similar Articles

Бионика Медиа